Quality of Life for Patients with Favorable Risk HPV-Associated Oropharyngeal Cancer After De-Intensified Chemoradiotherapy

We examined quality of life data from two prospective phase 2 studies of de-intensified chemoradiotherapy in patients with HPV-associated oropharyngeal cancer. Overall results were favorable, and most quality of life domains and symptoms returned to baseline by 3 to 6 months. Xerostomia and dysphagia continued to improve beyond 1 year post-treatment.

https://ift.tt/2P3ok6B